177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public. [PDF]
Schütze C +14 more
europepmc +1 more source
Correction: Iacovitti et al. The Prevalence and Malignancy Risk of Breast Incidental Uptake Detected by PET/CT with Different Radiopharmaceuticals: An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18, 1831. [PDF]
Iacovitti CM +8 more
europepmc +1 more source
Process-Related Incidents in Nuclear Medicine: A Four-Year Single-Center Retrospective Analysis to Support the Implementation of a Scenario-Based Radiopharmacy Training. [PDF]
Soualy Y +6 more
europepmc +1 more source
Pathways and challenges in the clinical translational of radiopharmaceuticals for pediatric investigations. [PDF]
Stauff E +6 more
europepmc +1 more source
Feasibility of albumin binding modulation in FAP-targeting radiopharmaceuticals: insights from molecular docking and experimental analysis. [PDF]
Shokrollahi S, Amiri A.
europepmc +1 more source
Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals. [PDF]
Napolitano R +12 more
europepmc +1 more source
Preliminary biological evaluation of a [<sup>177</sup>Lu]Lu-labeled peptide targeting Nectin-4. [PDF]
Li D +7 more
europepmc +1 more source
Co-57-based intercomparison of TLC scanners and dose calibrators for low-activity radiochemical purity assessment in radiopharmaceutical quality control. [PDF]
Straub M +5 more
europepmc +1 more source
RadioPharm: the database of radiopharmaceuticals. [PDF]
Liu J +17 more
europepmc +1 more source
Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer. [PDF]
Hunkeler BD +5 more
europepmc +1 more source

